FDA debate and vote on Covid booster shots

On sep 17th 2021 FDA The vaccine advisory committee debated and voted on the Pfizer and BioNTech’s application of booster shots for the general public. The vote comes as some  prominent scientists are leaving the FDA over pressure from the Biden administration to approve the shots. They said they weren’t entirely convinced every American needs extra doses at that time. 

 
 
The 2 scientists are Dr. Marion Gruber, the director of the FDA’s Office of Vaccines Research and Review, and her deputy, Dr. Philip Krause. More on that in the next video below
1:18:25 1:56: Presentation From Israel followed by Q&A 2:09
 
The strategy of dealing with Sars Cov2 in Israel has been, like in many other places in the world – predominantly the vaccine route.
 
2:17:00 Pfizer presentation
 
The FDA committee meeting is over 8 hours long. While I doubt anyone following this moving target and endowed with healthy logic, would feel the need for more proof on the safe and effective claims, I feel it is important to have a record of the debate in full.
 

Watch the next 2 videos below where Del and Jeremy from the Highwire analyse what went on and more

 
 
 

New york times: f.d.a. Authorizes pfizer booster shots for older and at-risk americans

Fda: fda authorizes booster dose of pfizer-biontech covid-19 vaccine for certain populations 

Abc: new florida surgeon general gives parents choice whether to quarantine students exposed to covid-19 

The telegraph: wuhan scientists planned to release coronavirus particles into cave bats, leaked papers reveal

Abc: lawsuit filed against the university system of maryland over vaccine mandates

The jerusalem post: was israel’s decision to give everyone covid boosters a shot in the dark?

Nejm: protection of bnt162b2 vaccine booster against covid-19 in israel

Medrxiv: waning immunity of the bnt162b2 vaccine: a nationwide study from israel

Medrxiv: six month safety and efficacy of the bnt162b2 mrna covid-19 vaccine

The bmj opnion: does the fda think these data justify the first full approval of a covid-19 vaccine?

Nature: covid vaccine immunity is waning — how much does that matter?

New york times: new study of covid booster shots fans debate over benefits

New york times: u.s. Booster policy is in flux as studies add to dissent
 

 

Good things come to those who sign up

Spread the love

Leave a Reply